Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy, Radiation, and ABMT for Extrachoroidal or Metastatic Retinoblastoma
NCT00004006Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Nov 1997
- Primary completion
- Sep 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin, etoposide, cyclophosphamide, doxorubicin and topotecan in retinoblastoma (Rb), sponsored by St. Jude Children's Research Hospital. Primary endpoints: Feasibility of sequential therapy, Treatment Response and 1 more. Started Nov 1997; status: completed.
02
Drugs
carboplatinetoposidecyclophosphamidedoxorubicintopotecan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT00004006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004006.